COQ7

Chr 16AR

coenzyme Q7, hydroxylase

Also known as: CAT5, COQ10D8, HMNR9

The protein encoded by this gene is similar to a mitochondrial di-iron containing hydroxylase in Saccharomyces cerevisiae that is involved with ubiquinone biosynthesis. Mutations in the yeast gene lead to slower development and longer life span. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismARLOEUF 1.492 OMIM phenotypes
Clinical SummaryCOQ7
🧬
Gene-Disease Validity (ClinGen)
distal hereditary motor neuropathy · ARStrong

Strong evidence — appropriate for clinical testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
13 unique Pathogenic / Likely Pathogenic· 110 VUS of 256 total submissions
📖
GeneReview available — COQ7
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.49LOEUF
pLI 0.000
Z-score 0.42
OE 0.86 (0.521.49)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
-0.46Z-score
OE missense 1.11 (0.971.27)
153 obs / 137.7 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.86 (0.521.49)
00.351.4
Missense OE?1.11 (0.971.27)
00.61.4
Synonymous OE?1.05
01.21.6
LoF obs/exp: 9 / 10.5Missense obs/exp: 153 / 137.7Syn Z: -0.28

This gene — mechanism propensity

DN
0.7325th %ile
GOF
0.6639th %ile
LOF
0.2969th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

256 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic5
VUS110
Likely Benign93
Benign21
Conflicting11
8
Pathogenic
5
Likely Pathogenic
110
VUS
93
Likely Benign
21
Benign
11
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
6
0
0
8
Likely Pathogenic
4
1
0
0
5
VUS
11
86
12
1
110
Likely Benign
1
4
48
40
93
Benign
0
4
15
2
21
Conflicting
11
Total181017543248

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

14 pathogenic / likely-pathogenic (of 21) ClinVar copy-number / structural variants overlap COQ7 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

COQ7 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →